Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 4Vitamin D Deficiency 2Triple Negative Breast Neoplasms 1Obesity 1Lymphoma, Non-Hodgkin 1Leukemia, Lymphocytic, Chronic, B-Cell 1Colonic Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Bone Metabolism Biomarkers 1

Interventions

Cyclophosphamide 28Rituximab 24fludarabine 15fludarabine phosphate 13Specimen Handling 12obinutuzumab 10ibrutinib 10Magnetic Resonance Spectroscopy 10Prednisone 8Mycophenolic Acid 8Doxorubicin 8tocilizumab 7polatuzumab vedotin 7X-Rays 7Whole-Body Irradiation 7Phantoms, Imaging 7Lenalidomide 7Etoposide 7Biopsy 7glofitamab 6Vincristine 6Melphalan 6Busulfan 6Bendamustine Hydrochloride 6venetoclax 5pirtobrutinib 5acalabrutinib 5Peripheral Blood Stem Cell Transplantation 5Nuclear Medicine Department, Hospital 5Nivolumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Non-Hodgkin × Cholecalciferol × 90 days × Clear all
NCT02553447 2026-04-21

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

University of Nebraska

Phase NA Completed
197 enrolled 15 charts
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Vitamin D Deficiency, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡